← FDA Drug Approvals (Drugs@FDA)

VIGABATRIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PROPEL PHARMA · Approved 2021-07-29

Drug application

FDA Application #

ANDA213390

Application type

Abbreviated New Drug Application (Generic)

Brand name

VIGABATRIN

Generic name

Vigabatrin

Active ingredients

VIGABATRIN

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

PROPEL PHARMA

First approval

2021-07-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown